The effect of three-monthly albendazole treatment on malarial parasitemia and allergy: a household-based cluster-randomized, double-blind, placebo-controlled trial.

<h4>Background</h4>Helminth infections are proposed to have immunomodulatory activities affecting health outcomes either detrimentally or beneficially. We evaluated the effects of albendazole treatment, every three months for 21 months, on STH, malarial parasitemia and allergy.<h4>...

Full description

Bibliographic Details
Main Authors: Aprilianto E Wiria, Firdaus Hamid, Linda J Wammes, Maria M M Kaisar, Linda May, Margaretta A Prasetyani, Sitti Wahyuni, Yenny Djuardi, Iwan Ariawan, Heri Wibowo, Bertrand Lell, Robert Sauerwein, Gary T Brice, Inge Sutanto, Lisette van Lieshout, Anton J M de Craen, Ronald van Ree, Jaco J Verweij, Roula Tsonaka, Jeanine J Houwing-Duistermaat, Adrian J F Luty, Erliyani Sartono, Taniawati Supali, Maria Yazdanbakhsh
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23526959/pdf/?tool=EBI